OUP (Osage University Partners)
47 portfolio companies · 8 on the map · $2.1B raised · 7 cities
Portfolio map
8 OUP (Osage University Partners) portfolio companies on the map.
Portfolio companies

Kura Oncology
San Diego
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
Biotechnology Research$1.2BEst. 2014
DELFI Diagnostics
Palo Alto
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Medical and Diagnostic Laboratories$364.8MEst. 2019
Corelight
San Francisco
Corelight transforms network data into definitive evidence, powering AI-driven detection and expert-authored workflows, and enabling the AI SOC ecosystem. Delivered by our open NDR platform, Corelight’s comprehensive, correlated evidence gives you unparalleled visibility into your network. This evidence allows you to unlock new analytics, investigate faster, hunt like an expert, and even disrupt future attacks. Our on-prem and cloud sensors go anywhere to capture structured, industry-standard telemetry and insights that work with the tools and processes you already use. Corelight’s global customers include Fortune 500 companies, major government agencies, and research universities. Get started >> https://www.corelight.com/contact
Computer and Network Security$309.2MEst. 2016
AssetWatch
Dublin
AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.
Automation Machinery Manufacturing$166.1MEst. 2014
SKYTREE
Amsterdam
Engineering the CO₂ transition
Climate Technology Product Manufacturing$8.7MEst. 2014- S
Synthorx
La Jolla
Synthorx is a biotechnology company using synthetic biology to synthesize solutions.
Biotechnology ResearchSeries CEst. 2014 Virtue AI
San Francisco
Virtue AI bridges the gap between AI product development and deployment for enterprises. We offer comprehensive, end-to-end AI safety and security solutions to ensure the safe, secure, and privacy-preserving deployment of AI products. Our advanced platform provides rigorous testing, alignment, and moderation across the AI lifecycle, proactively mitigating risks such as cybersecurity vulnerabilities, safety threats, and hallucination issues. Overall, Virtue AI deploys a rigorous testing framework for any AI model or system, offering actionable steps to mitigate potential risks. Our assessments empower enterprises to confidently leverage the power of AI while optimizing their systems and maintaining compliance. By combining expertise in machine learning, security, safety, law, and sociology, we bridge the gap between AI development and secure deployment, setting new standards for secure and responsible AI practices across industries. Our mission is to empower enterprises with innovative solutions that ensure responsible AI development and deployment. By continuously pushing the boundaries of AI safety research and sharing our findings, we contribute to elevating the AI safety community and creating a safer digital future.
Technology, Information and InternetSeries AEst. 2024
Quantum Circuits
Connecticut
Quantum Circuits is developing a full-stack quantum computing platform using superconducting devices with a modular, scalable architecture, aiming to build the first truly useful quantum computers. The company stems from Yale University’s q
Computer HardwareSeries BEst. 2015
More portfolio companies
39 more OUP (Osage University Partners) investments we track beyond the map.
BioAge LabsRichmond · Series D
Menlo SecurityMountain View · Series E
Terremoto BiosciencesSan Francisco · Series C
MetalenzBoston · Series B
Hack The BoxFolkestone · Series B
Precede BiosciencesBoston · Series B
StreetLight DataSan Francisco · Series D
MicroTransponderDallas · Series F
NuMat TechnologiesSkokie · Series B
Bristol-Myers SquibbNew York · Post-IPO Equity
Q32 BioCambridge · Post-IPO Equity
Xscape PhotonicsNew York · Series A
ReCode TherapeuticsDallas · Series B
EmbodiedPasadena · Series A
SiFiveSan Mateo · Series E
MC10Lexington · Venture
Arrakis TherapeuticsWaltham · Series B
RapidFire AIPalo Alto · Pre-Seed
Vanqua BioChicago · Series B
SeismosAustin · Venture
Pionyr ImmunotherapeuticsSouth San Francisco · Series B
AlgorithmiaSeattle · Series B
Opsys TechHolon · Series C
Vector LaunchHuntington Beach · Series B
Spero TherapeuticsCambridge · Post-IPO Equity
ClinipaceMorrisville · Venture
Perceptive AutomataBoston · Seed
Medisix TherapeuticsSingapore · Series A
Neuros MedicalWilloughby · Series D
LastlineRedwood City · Series C
LunaDNASan Diego · Venture
AGTCAlachua · Series B
Escient PharmaceuticalsSan Diego · Series C
Homology MedicinesLexington · Series B
University of Puerto Rico-BayamonSan Juan · Grant
CounterFlowCrozet · Seed
Aerie PharmaceuticalsBedminster · Series B
LuxteraCarlsbad · Series D
ReceptosSan Diego · Series B
Portfolio map
8 OUP (Osage University Partners) portfolio companies on the map.